Amidated insulin glargine

Details Amidated insulin glargine Amidated insulin glargine

2009-01-07

2011-11-01

Romeo, David (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S006200, C514S006500, C514S007200, C514S011700, C530S303000, C530S308000

Reexamination Certificate

active

08048854

ABSTRACT:
The invention relates to insulin glargine which is modified by amidation, especially Gly(A21), Arg(B31), Arg amide (B32) human insulin (insulin glargine amide).

REFERENCES:
patent: 5227293 (1993-07-01), Stengelin et al.
patent: 5656722 (1997-08-01), Dorschug et al.
patent: 5663291 (1997-09-01), Obermeier et al.
patent: 6528486 (2003-03-01), Larsen et al.
patent: 6875589 (2005-04-01), Dorschug et al.
patent: 2006/0120969 (2006-06-01), Nilsson et al.
patent: 0132769 (1985-02-01), None
patent: 0214826 (1987-03-01), None
patent: 0254516 (1988-01-01), None
patent: 0294851 (1988-12-01), None
patent: 0140084 (1990-06-01), None
patent: 0229998 (1992-07-01), None
patent: 0376156 (1996-03-01), None
patent: WO 01/04156 (2001-01-01), None
patent: WO 02/066628 (2002-08-01), None
patent: WO 02/068660 (2002-09-01), None
patent: WO 02/070722 (2002-09-01), None
patent: WO 03/044210 (2003-05-01), None
patent: WO 03/105888 (2003-12-01), None
patent: WO 2004/005342 (2004-01-01), None
patent: WO 2006/015879 (2006-02-01), None
patent: WO 2006/058620 (2006-06-01), None
patent: WO 2007/036299 (2007-04-01), None
Barnett, A., et. al. , Insulin Analogues, The Lancet, vol. 349, pp. 47-51, (1997).
Hartmann, H., et. al., Biological Activity of des-B26-1330)-Insulinamide and Related Analogues in Rat Hepatocyte Cultures, Diabetologia, (1989), vol. 32, pp. 416-420.
Leyer et al, The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone, International Journal of Peptide & Protein Research, vol. 46, No. 5, Nov. 1995, pp. 397-407.
Sanger, F., et. al., The Amide Groups of Insulin, The Biochemical Joumal, (1955) vol. 59, No. 3, pp. 509-518.
Schellenberger et al., Attempts for Quanitfying the S′ Subsite Specificity of Serine Proteases, Advances in the Biosciences, Peptides and Proteases: Recent Advances; Selected Papers Presented At the 2nd International Meeting on the Molecular and Cellular Regulation of Enzyme Activity, vol. 65, (1987), pp. 159-166.
Schellenberger et al., Protease-Catalyzed Kinetically Controlled Peptide Synthesis, Angewante Chemie, International Ediition, vol. 30, No. 11, 1991, pp. 1437-1449.
The Effect of Intensive Treatment of Diabetes on the Developement and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, The New England Journal of Medicine vol. 329, No. 14, pp. 977-986 (1993).

Affiliated with

Also associated with

Rating

Amidated insulin glargine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amidated insulin glargine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidated insulin glargine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4297878